NextCure, Inc.(NXTC)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

NextCure, Inc. (NXTC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NXTC is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 30 institutional filers currently hold this stock. Top institutional holders of NXTC by reported 13-F value include Ikarian Capital, ADAGE CAPITAL PARTNERS GP, L.L.C., Sofinnova Ventures, based on the most recent SEC filings. NXTC trades on the Nasdaq exchange and files with the SEC under CIK 1661059. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NXTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NextCure, Inc. directly from SEC EDGAR.

Net Income

$-14.9M

NXTC key financials by period

NextCure, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202010-K$22.4M$-36.6M-184.2%
FY 201910-K$6.3M$-33.7M—

Institutions holding NXTC

Institutional investors reporting a position in NextCure, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Ikarian Capital288,303$461.3K2026-06-30
ADAGE CAPITAL PARTNERS GP, L.L.C.277,202$443.5K2026-06-30
Sofinnova Ventures222,654$356.2K2026-06-30
RENAISSANCE TECHNOLOGIES171,202$273.9K2026-06-30
VANGUARD CAPITAL MANAGEMENT156,842$250.9K2026-06-30
MILLENNIUM MANAGEMENT88,112$141.0K2026-06-30
BOOTHBAY FUND MANAGEMENT84,687$135.5K2026-06-30
Squadron Capital Management64,464$103.1K2026-06-30
Verdad Advisers60,451$96.7K2026-06-30
PFIZER44,347$73.0K2026-06-30
SEC EDGAR: CIK 1661059 →
NXTC

NextCure, Inc.

NXTC
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 30 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-14.89M

EPS (Diluted)

Q2 2026
EDGAR

$-2.80

Top Institutional Holders

as of Q2 2026
$2.78M total
Ikarian Capital, LLC
$461.3K+21.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$443.5KNew
Sofinnova Ventures Inc
$356.2K0.0%
RENAISSANCE TECHNOLOGIES LLC
$273.9K+182.8%
VANGUARD CAPITAL MANAGEMENT LLC
$250.9KNew
MILLENNIUM MANAGEMENT LLC
$141.0KNew
BOOTHBAY FUND MANAGEMENT, LLC
$135.5K+21.6%
Squadron Capital Management LLC
$103.1K-75.7%
Verdad Advisers, LP
$96.7K+40.7%
PFIZER INC
$73.0K-71.1%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…